Heo Jung Ho, Brugaletta Salvatore, Garcia-Garcia Hector M, Gomez-Lara Josep, Ligthart Jurgen M R, Witberg Karen, Magro Michael, Shin Eun-Seok, Serruys Patrick W
Department of Interventional Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands.
Catheter Cardiovasc Interv. 2014 Jun 1;83(7):E233-42. doi: 10.1002/ccd.23335. Epub 2013 Nov 30.
iMAP is a new intravascular ultrasound (IVUS) derived technique for tissue characterization using spectral analysis. Since there is a need for reproducibility data to design longitudinal studies, we sought to assess the in vivo reproducibility of this imaging technique.
iMAP (40 MHz, Boston Scientific Corporation) was performed in patients referred for elective percutaneous intervention and in whom a nonintervened vessel was judged suitable for a safe IVUS analysis. Overall 20 patients with 20 non-angiographically significant lesions were assessed by two independent observers. Five of these 20 patients received an additional iMAP analysis using a new IVUS catheter and using the same catheter after its engagement and reengagement.
The interobserver relative difference in plaque area was 2.5%. Limits of agreement for lumen, vessel, and plaque area measurements were 1.62, -2.47 mm(2) ; 2.09, -3.71 mm(2) ; 2.80, -3.72 mm(2) ; respectively. Limits of agreement for fibrotic, lipidic, necrotic, and calcified measurements were 1.32, -1.44 mm(2) ; 0.24, -0.36 mm(2) ; 1.50, -2.26 mm(2) ; 0.09, -0.11 mm(2) ; respectively. The intercatheter and intracatheter relative difference in plaque area were 0.9% and 4.1%, respectively. Although the variability for compositional measurements increased using two different catheters or using the same catheter twice, the variability for compositional measurements keeps always below 10%.
Our analysis demonstrates that the geometrical and compositional iMAP analysis is acceptably reproducible.
iMAP是一种新的血管内超声(IVUS)衍生技术,用于通过光谱分析进行组织特征描述。由于设计纵向研究需要可重复性数据,我们试图评估这种成像技术的体内可重复性。
对因择期经皮介入治疗而转诊且非介入血管被判定适合进行安全IVUS分析的患者进行iMAP(40 MHz,波士顿科学公司)检查。共有20例患者的20个非血管造影显著病变由两名独立观察者进行评估。这20例患者中有5例使用新的IVUS导管以及同一导管在插入和重新插入后再次接受iMAP分析。
观察者间斑块面积的相对差异为2.5%。管腔、血管和斑块面积测量的一致性界限分别为1.62,-2.47平方毫米;2.09,-3.71平方毫米;2.80,-3.72平方毫米。纤维化、脂质、坏死和钙化测量的一致性界限分别为1.32,-1.44平方毫米;0.24, -0.36平方毫米;1.50,-2.26平方毫米;0.09,-0.11平方毫米。导管间和导管内斑块面积的相对差异分别为0.9%和4.1%。尽管使用两种不同导管或同一导管两次时成分测量的变异性增加,但成分测量的变异性始终保持在10%以下。
我们分析表明,iMAP的几何和成分分析具有可接受的可重复性。